MedTrace Logo

TRIAD Burden of Illness Mucositis Study

NCT00336609 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2007-04-20

No results posted yet for this study

Summary

Observational (non-drug) study to look at the risks and burden of mucositis (sores) involving the mouth, throat and intestines in patients receiving chemotherapy and radiation therapy treatment for various cancer types.

Conditions

  • Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine)

Sponsors & Collaborators

  • TRIAD Burden of Illness

    lead OTHER

Principal Investigators

  • Sonis T Sonis, DMD, DMSc · Brigham and Women's Hospital

  • Dorothy Keefe, MD · University of Adelaide

  • Linda Elting, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00336609 on ClinicalTrials.gov